Nanollose Ltd. (AU:NC6)
ASX:NC6
Want to see AU:NC6 full AI Analyst Report?
NC6 Stock Chart & Stats
AU$0.05
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.05
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.09
Previous CloseN/A
Volume1.00
Average Volume (3M)138.71K
Market Cap
AU$27.81M
Enterprise ValueAU$23.84M
Total Cash (Recent Filing)AU$274.97K
Total Debt (Recent Filing)AU$250.21K
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding408,954,380
10 Day Avg. Volume179,263
30 Day Avg. Volume138,709
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)34.86
Price to Sales (P/S)0.00
P/FCF Ratio-12.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustainable Microbial-cellulose TechnologyNanollose’s core technology—microbial cellulose produced via fermentation—aligns with structural demand for sustainable textile inputs. This manufacturing approach can lower reliance on trees/cotton, create differentiated product positioning, and support long-term premium or regulatory-driven adoption if scaled.
Low Leverage / Limited DebtA low-debt balance sheet reduces near-term solvency and interest-burden risk, giving management financial optionality. This structural strength allows the company to pursue R&D, partnerships or scaling initiatives with less immediate refinancing pressure compared with highly leveraged peers.
Multiple Application PathwaysHaving product applications across textiles, nonwovens and biomaterials provides several commercialization routes. Diversified end-markets reduce concentration risk, enable strategic partnerships or licensing in the strongest verticals, and improve the odds of sustainable revenue emergence over time.
Bears Say
Persistent UnprofitabilitySustained negative profitability prevents internal funding of growth, constrains reinvestment into manufacturing scale or commercialisation, and weakens long-term return on equity. Without a credible path to positive margins, the business relies on external capital, raising dilution and execution risk.
Revenue Collapse And VolatilityRevenue falling to zero signals failure to convert technology into stable sales or episodic revenue recognition. Such volatility undermines planning, prevents economies of scale in production, and makes it difficult to attract strategic partners or long-term contracts required for durable commercial success.
Weak Operating Cash GenerationConsistent negative operating and free cash flow mean the company is burning cash and depends on external financing. Even with low debt, prolonged cash outflows force equity raises or debt issuance, which can dilute shareholders, increase financing costs, and constrain long-term investment in scale-up.
Nanollose Ltd. News
NC6 FAQ
What was Nanollose Ltd.’s price range in the past 12 months?
Nanollose Ltd. lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
What is Nanollose Ltd.’s market cap?
Nanollose Ltd.’s market cap is AU$27.81M.
When is Nanollose Ltd.’s upcoming earnings report date?
Nanollose Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 85 days.
How were Nanollose Ltd.’s earnings last quarter?
Nanollose Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Nanollose Ltd. overvalued?
According to Wall Street analysts Nanollose Ltd.’s price is currently Overvalued.
Does Nanollose Ltd. pay dividends?
Nanollose Ltd. does not currently pay dividends.
What is Nanollose Ltd.’s EPS estimate?
Nanollose Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanollose Ltd. have?
Nanollose Ltd. has 408,954,380 shares outstanding.
What happened to Nanollose Ltd.’s price movement after its last earnings report?
Nanollose Ltd. reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.389%.
Which hedge fund is a major shareholder of Nanollose Ltd.?
Currently, no hedge funds are holding shares in AU:NC6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanollose Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
188.88%
12-Months-Change
Fundamentals
Return on Equity
-1964.93%
Trailing 12-Months
Asset Growth
-23.63%
Trailing 12-Months
Company Description
Nanollose Ltd.
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, nonwoven fabric, and other industries. The company was incorporated in 2014 and is based in Nedlands, Australia.
Technical Analysis
Prescient Therapeutics Limited
―
AnteoTech Ltd
―
Regeneus Ltd.
―
AdAlta Ltd.
―
Arovella Therapeutics Limited
―
Options Prices
Currently, No data available
---